These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 20058397

  • 21. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L, Huot C, Lambert R, Deal C, Collu R, Van Vliet G.
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [Abstract] [Full Text] [Related]

  • 22. Medical treatment of hyperthyroidism: state of the art.
    Fumarola A, Di Fiore A, Dainelli M, Grani G, Calvanese A.
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):678-84. PubMed ID: 20496313
    [Abstract] [Full Text] [Related]

  • 23. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
    Chen CH, Xirasagar S, Lin CC, Wang LH, Kou YR, Lin HC.
    BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
    [Abstract] [Full Text] [Related]

  • 24. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
    Wang MT, Lee WJ, Huang TY, Chu CL, Hsieh CH.
    Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic drug monitoring of antithyroid drugs in pregnancy: the knowledge gaps.
    Clementi M, Gianantonio E.
    Ther Drug Monit; 2006 Aug; 28(4):576; author reply 576. PubMed ID: 16885728
    [No Abstract] [Full Text] [Related]

  • 26. Thyroid suppression test as index of outcome of hyperthyroidism treated with antithyroid drugs.
    Cassidy CE.
    Metabolism; 1970 Oct; 19(10):745-50. PubMed ID: 4096944
    [No Abstract] [Full Text] [Related]

  • 27. Liver failure due to antithyroid drugs: report of a case and literature review.
    Livadas S, Xyrafis X, Economou F, Boutzios G, Christou M, Zerva A, Karachalios A, Palioura H, Palimeri S, Diamanti-Kandarakis E.
    Endocrine; 2010 Aug; 38(1):24-8. PubMed ID: 20960098
    [Abstract] [Full Text] [Related]

  • 28. The efficiency and safety of methimazole and propylthiouracil in hyperthyroidism: A meta-analysis of randomized controlled trials.
    Tan S, Chen L, Jin L, Fu X.
    Medicine (Baltimore); 2021 Jul 30; 100(30):e26707. PubMed ID: 34397700
    [Abstract] [Full Text] [Related]

  • 29. Leukocytoclastic vasculitis: a rare manifestation of propylthiouracil hypersensitivity.
    Erem C, Yucel Y, Ya Z, Reis A, Kocak M, Hacihasanoglu A.
    Med Princ Pract; 2005 Jul 30; 14(5):366-9. PubMed ID: 16103706
    [Abstract] [Full Text] [Related]

  • 30. [Usefulness and risks of thyreostatic substances from a radiologic viewpoint].
    Ammon J, Karstens JH.
    Med Welt; 1982 Oct 15; 33(41):1417-24. PubMed ID: 6185819
    [No Abstract] [Full Text] [Related]

  • 31. A Disproportionality Analysis of the Adverse Effect Profiles of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Using the Japanese Adverse Drug Event Report Database.
    Arai M, Tsuno T, Konishi H, Nishiyama K, Terauchi Y, Inoue R, Shirakawa J.
    Thyroid; 2023 Jul 15; 33(7):804-816. PubMed ID: 37130038
    [Abstract] [Full Text] [Related]

  • 32. [Dissociated cholestasis secondary to methimazole in amiodaron-related hyperthyroidism].
    García Lobato E, García Lobato C, Briegas Morera D, Rangel Mayoral JF.
    Farm Hosp; 2016 Sep 01; 40(5):449-50. PubMed ID: 27570995
    [No Abstract] [Full Text] [Related]

  • 33. Acute Liver Failure: A Potential Complication of Antithyroid Medication Use.
    Chou C, Wong RJ, Higgins JP, Perumpail RB, Ahmed A.
    Dig Dis Sci; 2015 Jul 01; 60(7):1924-7. PubMed ID: 25366145
    [No Abstract] [Full Text] [Related]

  • 34. Medical management of hyperthyroidism.
    Trepanier LA.
    Clin Tech Small Anim Pract; 2006 Feb 01; 21(1):22-8. PubMed ID: 16584027
    [Abstract] [Full Text] [Related]

  • 35. [Effects of maternal hyperthyroidism and antithyroid drug therapy on congenital malformation of newborn infants].
    Lian XL, Bai Y, Xu YH, Dai WX, Guo ZS.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug 01; 40(8):511-5. PubMed ID: 16202286
    [Abstract] [Full Text] [Related]

  • 36. Prolonged drug treatment of hyperthyroidism.
    Burrows BA, Slingerland DW.
    Trans Am Clin Climatol Assoc; 1977 Aug 01; 88():219-26. PubMed ID: 70878
    [No Abstract] [Full Text] [Related]

  • 37. [The use of antithyroid drugs should be reduced as much as possible in the first trimester].
    Andersen SL, Laurberg P.
    Ugeskr Laeger; 2014 Sep 22; 176(39):. PubMed ID: 25294327
    [Abstract] [Full Text] [Related]

  • 38. Management of hyperthyroidism during pregnancy and lactation.
    Azizi F, Amouzegar A.
    Eur J Endocrinol; 2011 Jun 22; 164(6):871-6. PubMed ID: 21389085
    [Abstract] [Full Text] [Related]

  • 39. Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008.
    Emiliano AB, Governale L, Parks M, Cooper DS.
    J Clin Endocrinol Metab; 2010 May 22; 95(5):2227-33. PubMed ID: 20335447
    [Abstract] [Full Text] [Related]

  • 40. Pharmacologic treatment of hyperthyroidism during pregnancy.
    Cassina M, Donà M, Di Gianantonio E, Clementi M.
    Birth Defects Res A Clin Mol Teratol; 2012 Aug 22; 94(8):612-9. PubMed ID: 22511519
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.